Corteva (CTVA) is a Basic Materials company in the Agricultural Inputs industry. It has a market capitalization of $7.94B, a trailing price-to-earnings ratio of 3.1 and a free-cash-flow yield of 34.7%. Over the most recent reported fiscal year, revenue grew 2.9% and free cash flow per share grew 85.7%. Nama's AI scorecard rates it Buy, 6.0 out of 10. On 12-month momentum it ranks in the trailing band of its market.
AI scorecard
Buy · 6.0/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Trailing · -77.1% over 12 months ex. last
Bottom 20% of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-86.9%
How far the last close sits under the highest price of the past five years.
Market cap
$7.94B
Trailing P/E
3.1
Price / book
0.3
Price / sales
1.6
FCF yield
34.7%
Dividend yield
6.0%
Gross margin
48.6%
Operating margin
16.5%
Net margin
6.5%
Revenue growth (YoY)
+2.9%
Revenue growth (3-yr annual)
-0.1%
EPS growth (YoY)
+30.2%
FCF/share growth (YoY)
+85.7%
Beta
—
Exchange
NYSE
Sector
Basic Materials
Industry
Agricultural Inputs
CTVA earnings
Next report: Nov 11, 2026 (Q3 2026, EPS estimate $0.10).
Beat the EPS estimate in 3 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q2 2026
Jul 30, 2026
$2.30
$2.23
+3.1%
—
Q1 2026
May 5, 2026
$1.50
$1.18
+27.1%
$4.91B
Q4 2025
Feb 3, 2026
$0.22
$0.22
+0.0%
$3.91B
Q3 2025
Nov 4, 2025
-$0.23
-$0.47
+51.1%
$2.62B
CTVA analyst price target
Median target $17.00 from 13 analysts, ranging $13.65 – $20.00.
Nama's AI scorecard currently rates Corteva Buy (6.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CTVA's P/E ratio?
Corteva trades at a trailing price-to-earnings ratio of 3.1.
When does CTVA report earnings?
Corteva's next scheduled report is on Nov 11, 2026. Analysts expect EPS of $0.10.
What is the CTVA price target?
The median analyst price target from 13 analysts is $17.00, with a range of $13.65 – $20.00.
Is CTVA Shariah compliant?
Nama's AAOIFI-style screen reads Corteva as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.